 "pharma")
FDC was up 7% to Rs 256 on BSE ahead of board meeting today to consider share buyback proposal and unaudited financial results for the quarter ended December 2017.
“The board of directors shall meet on February 8, 2017 to consider the proposal for buyback of fully paid up equity shares of the Company through tender offer route, up to such amount of the aggregate of Company's paid up equity share capital and free reserves as the Board may decide,” FDC on February 3, 2018 said in a BSE filing.
Earlier, on January 09, 2018, the pharmaceutical company
“The board of directors shall meet on February 8, 2017 to consider the proposal for buyback of fully paid up equity shares of the Company through tender offer route, up to such amount of the aggregate of Company's paid up equity share capital and free reserves as the Board may decide,” FDC on February 3, 2018 said in a BSE filing.
Earlier, on January 09, 2018, the pharmaceutical company
